Stereotaxis, Inc. (STXS)
1.90
+0.05
(+2.70%)
USD |
NYAM |
May 21, 16:00
1.90
0.00 (0.00%)
Pre-Market: 19:59
Stereotaxis Research and Development Expense (TTM) : 9.43M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Myomo, Inc. | 6.777M |
| TransMedics Group, Inc. | 76.77M |
| CONMED Corp. | 59.27M |
| Escalon Medical Corp. | 0.6688M |
| IRIDEX Corp. | 3.697M |